Kissei Pharmaceutical Co., Ltd. planned to acquire treasury shares based on the board of directors’ resolution on May 11, 2026, from May 12, 2026, to December 31, 2026. However, the actual number of shares acquired was 0 shares, and the total amount was 0 yen.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4547","jir_company_name":"Kissei Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2606\u2606\u2606","jir_publication_date":"2026-06-03","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/06\/4547-20260603-01.pdf","jir_short_summary":"Kissei Pharmaceutical Co., Ltd. planned to acquire treasury shares based on the board of directors' resolution on May 11, 2026, from May 12, 2026, to December 31, 2026. However, the actual number of shares acquired was 0 shares, and the total amount was 0 yen.","jir_summary":"### Overview of Capital Policy\nKissei Pharmaceutical Co., Ltd. planned to acquire up to 1,300,000 shares (3.14% of total issued shares) as treasury stock following the board resolution on May 11, 2026. As of May 31, 2026, the cumulative total acquired shares remain at 0, and the total acquisition amount is also 0 yen. The acquisition method involved a market purchase on the Tokyo Stock Exchange and was based on an entrusted trading agreement.\n\n### Future Outlook and Impact on Shareholders\nThe results show that the intended acquisition was not realized, indicating that the share buyback as part of the capital policy has possibly been postponed. Further announcements will be needed regarding future capital policies and shareholder return strategies. Investors should closely monitor the implementation status of the share buyback and future policy directions.","jir_financial_highlights":"Total Number of Shares Acquired: 0 shares (Unknown)\nTotal Acquisition Cost: 0 yen (Unknown)\nAcquisition Period: May 12, 2026 \u2013 December 31, 2026 (Unknown)","jir_category":"","jir_hashtags":"#KisseiPharmaceutical, #ShareBuyback, #JapanStocks","jir_key_figures":"Total Number of Shares Acquired: 0 shares\nTotal Acquisition Cost: 0 yen\nAcquisition Period: May 12, 2026 \u2013 December 31, 2026","jir_meta_title":"\u3010Kissei Pharmaceutical\u3011Share Buyback Plan and Results | June 2026","jir_meta_description":"Kissei Pharmaceutical planned to acquire treasury shares in May 2026, but the actual acquisition was zero shares with a total amount of 0 yen. Attention to future capital policies is important.","jir_og_title":"\u3010Kissei Pharmaceutical\u3011Share Buyback Plan and Results | June 2026","jir_og_description":"Kissei Pharmaceutical's share buyback plan was not implemented, drawing attention to future capital policies. Details can be confirmed in IR materials.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":8930,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_buyback","footnotes":""},"sector":[],"importance":[],"class_list":["post-56573","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n